The company claims Botox should be excluded from Inflation Reduction Act (IRA) pricing negotiations due to its status as a plasma-derived drug, which is meant to be excluded from IRA negotiations.

Supreme Group has added Broth to the mix of ad agencies it has cooked up in recent years. Backed by a private equity firm, Supreme has bought companies in quick succession to strengthen its marketing and communications capabilities.

Alnylam achieved profitability for the first time in its history in 2025. But disappointing sales performance from Amvuttra in the closely watched ATTR-CM market and some expected turbulence in 2026 are weighing on its shares.

One day after CSL revealed that it had suddenly replaced its CEO, the company provided dismal financial figures that helped explain why it is undergoing the leadership change. In its half-year report, CSL said that its net profit plummeted from $2 billion in the second half of 2024 to $384 […]

Garijo’s appointment restores a single female CEO to the ranks of the top 10 Big Pharma companies

Massachusetts’ largest life science employer has put more than 630,000 square feet of office space on the sublease market as part of efforts to consolidate the Japanese company’s U.S. corporate hub at a new Cambridge development scheduled to open later this year.